Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 297.09 USD | +1.19% |
|
+6.08% | -1.95% |
| 07-01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 06-03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 7,948 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | -3.22% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 7,199 | 6,982 | 6,841 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | -8.58% | -3.01% | -2.02% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 35.7x | 34.9x | 35.2x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | 1.15x | 1.11x | - |
| PEG | - | - | - | -0x | -0x | -0.5x | 15.28x | -49.93x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.1x | 3.02x | 2.97x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 2.8x | 2.65x | 2.56x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 18.1x | 16.4x | 15.5x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 27x | 23.4x | 21.2x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 23.1x | 22.3x | 21x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 4.33% | 4.49% | 4.76% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,567 | 2,635 | 2,676 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 398.6 | 426.3 | 442.3 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 266.8 | 298 | 322 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 297.09 | 297.09 | 297.09 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,762 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.71x | 2.8x | 18.06x | -.--% | 7.95B | |
| 22.8x | 3.43x | 12.87x | 2.76% | 161B | |
| 17.95x | 3.16x | 11.13x | 3.74% | 101B | |
| 15.86x | 0.18x | 11.37x | 0.82% | 56.12B | |
| 32.74x | 7.95x | 20.8x | 1.23% | 53.35B | |
| 38.1x | 3.02x | 10.38x | 2.52% | 42.13B | |
| 39.95x | 1.44x | 12.67x | 0.2% | 35.29B | |
| 28.13x | 5.01x | 15.96x | -.--% | 26.57B | |
| 43.35x | 7.52x | 27.13x | 0.25% | 25.79B | |
| 23.36x | 3.42x | 12.28x | 1.24% | 20.69B | |
| Average | 29.79x | 3.79x | 15.27x | 1.28% | 52.98B | |
| Weighted average by Cap. | 25.98x | 3.59x | 13.87x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
